TympaHealth develops Tympa Assist, a multi-component AI-guided platform combining high-definition digital otoscopy, Otoscopy Assist (real-time AI feedback on image quality and wax level estimation), hearing screening, audiogram assistance, microsuction capability, and cloud-based referral pathways. The system is designed to support non-specialist practitioners—pharmacists, care providers and GPs—in making consistent assessments and referral decisions for non-complex ear and hearing presentations. The company positions the platform to ease pressure on ENT and audiology services by enabling more routine care in community settings and aligning with NHS Neighbourhood Health Service ambitions. TympaHealth is explicit that Tympa Assist is not intended for known or suspected complex ENT conditions and keeps clinical judgement with trained practitioners. The recent £2 million Innovate UK loan will fund feature expansion, clinical diagnostic builds, and integration with referral pathways to support product scaling and NHS alignment. The company aims to demonstrate safe, effective use of AI in frontline workflows to secure public procurement and wider clinical adoption.

Total raised

$34M

Funding rounds

3

Latest round

Debt Financing

Latest activity

May 2026